• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

立体定向乳腺活检:初步经验及改进建议

Stereotactic breast biopsy: initial experience and recommendations for improvement.

作者信息

Boes C J, Elson J D, Call J E

机构信息

Department of Radiology, Bishop Clarkson Memorial Hospital.

出版信息

Nebr Med J. 1993 Dec;78(12):380-2.

PMID:8309490
Abstract

The results of 54 stereotactic core breast biopsies performed at Bishop Clarkson Memorial Hospital were reviewed. In 47 biopsies (87% of the total), a definitive diagnosis of either benign or malignant was made. Two biopsies (4% of the total) were classified as missed, and 5 biopsies (9% of the total) were deemed indeterminate. To improve both the success of the procedure and patient management, six recommendations were made: Patients judged to be potentially uncooperative and inclined to move during the procedure should receive sedation. A post-biopsy, non-stereo film should be taken to determine whether additional stereotactic biopsies will be required to adequately sample the lesion. Lesions containing microcalcifications should have a specimen radiograph prior to completing the biopsy procedure. A history sheet including clinical and mammographic findings should be given to pathology along with the biopsy specimen to assist in the histologic interpretation. The radiologist should review the pathology results in order to determine if a miss has occurred and additional biopsy is indicated. Six-month follow-up mammograms are to be required following a benign stereotactic biopsy diagnosis.

摘要

回顾了在主教克拉克森纪念医院进行的54例乳腺立体定向核心活检的结果。在47例活检(占总数的87%)中,做出了良性或恶性的明确诊断。2例活检(占总数的4%)被归类为漏诊,5例活检(占总数的9%)被判定为不确定。为了提高手术成功率和患者管理水平,提出了六项建议:被判定在手术过程中可能不合作且容易移动的患者应接受镇静。活检后应拍摄非立体片,以确定是否需要额外的立体定向活检来充分采集病变样本。含有微钙化的病变在完成活检程序前应进行标本射线照相。应将包括临床和乳房X线摄影结果的病史表与活检标本一起交给病理科,以协助组织学解释。放射科医生应复查病理结果,以确定是否发生漏诊以及是否需要进行额外的活检。良性立体定向活检诊断后需进行六个月的乳房X线摄影随访。

相似文献

1
Stereotactic breast biopsy: initial experience and recommendations for improvement.立体定向乳腺活检:初步经验及改进建议
Nebr Med J. 1993 Dec;78(12):380-2.
2
Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.立体定向乳腺穿刺活检是评估乳腺钼靶检查发现的不可触及异常的一种准确诊断技术。
J La State Med Soc. 1996 Apr;148(4):167-70.
3
Stereotactic breast biopsy in a community hospital setting.
Am Surg. 1999 Aug;65(8):737-40; discussion 740-1.
4
[Stereotactic excisional nonpalpable breast lesions using the advanced breast biopsy instrumentation].使用先进乳腺活检器械对乳腺不可触及病变进行立体定向切除
J Gynecol Obstet Biol Reprod (Paris). 2000 Apr;29(2):142-7.
5
MR-guided stereotactic breast biopsy: technical aspects and preliminary results.磁共振引导下的立体定向乳腺活检:技术要点与初步结果
Radiol Med. 2003 Sep;106(3):232-44.
6
[Stereotactic vacuum-assisted breast biopsy - analysis of 166 cases].[立体定向真空辅助乳腺活检——166例分析]
Zentralbl Gynakol. 2004 Apr;126(2):87-92. doi: 10.1055/s-2004-818774.
7
[Stereotaxic excisional biopsy of non-palpable breast lesions by the ABBI(Advanced Breast Biopsy Instrumentation) technique. Advantages. Disadvantages. Indications. Apropos of 67 cases].
J Med Liban. 2000 Mar-Apr;48(2):70-6.
8
Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre.真空辅助立体定向引导乳腺旋切活检术在乳腺筛查发现的微钙化灶处理中的应用:大型乳腺筛查中心的经验
J Clin Pathol. 2008 Jun;61(6):766-9. doi: 10.1136/jcp.2007.054130. Epub 2008 Mar 6.
9
Follow-up recommendations for benign breast biopsies.乳腺良性活检的随访建议。
Breast J. 2006 Sep-Oct;12(5):413-7. doi: 10.1111/j.1075-122X.2006.00302.x.
10
Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?经粗针活检诊断的小叶原位癌:何时应进行切除?
Mod Pathol. 2003 Feb;16(2):120-9. doi: 10.1097/01.MP.0000051930.68104.92.